UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053691
Receipt number R000061272
Scientific Title Aerobic exercise habits may be associated with lower systemic cellular immune inflammation and higher albumin-to-globulin ratio: implication of preventive effect of aerobic exercise on atherosclerotic cardiovascular disease
Date of disclosure of the study information 2024/03/01
Last modified on 2025/02/23 15:06:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Aerobic exercise habits may be associated with lower systemic cellular immune inflammation and higher albumin-to-globulin ratio: implication of preventive effect of aerobic exercise on atherosclerotic cardiovascular disease

Acronym

Aerobic exercise habits may be associated with lower systemic cellular immune inflammation and higher albumin-to-globulin ratio: implication of preventive effect of aerobic exercise on atherosclerotic cardiovascular disease

Scientific Title

Aerobic exercise habits may be associated with lower systemic cellular immune inflammation and higher albumin-to-globulin ratio: implication of preventive effect of aerobic exercise on atherosclerotic cardiovascular disease

Scientific Title:Acronym

Association of inflammation and A/G ratio with aerobic exercise habits

Region

Japan


Condition

Condition

Atherosclerotic cardiovascular disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to investigate the association between aerobic exercise habits, AGR, and cellular immune-inflammation markers in annually health-checked participants with no ASCVD history and examined the role of cellular immune inflammation markers as a mediator in the association between aerobic exercise habits and AGR using causal median analysis.

Basic objectives2

Others

Basic objectives -Others

This study aimed to investigate the association between aerobic exercise habits, AGR, and cellular immune-inflammation markers in annually health-checked participants with no ASCVD history and examined the role of cellular immune inflammation markers as a mediator in the association between aerobic exercise habits and AGR using causal median analysis.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

to investigate the association between aerobic exercise habits, AGR, and cellular immune-inflammation markers in annually health-checked participants with no ASCVD history

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

participants receving annual health check

Key exclusion criteria

refusal to provide informed consent: ASCVD history; white blood cell count more than 10,000, C-reactive protein level more than 2.0 mg/dL, positive for hepatitis B virus surface antigen, hepatitis C antibodies, liver cirrhosis, hepatocellular carcinoma, or metastatic liver cancer, or nephrosis, multiple myeloma, hyperthyroidism or absent data for WBC count, CRP levels, and AGR.

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Shigemasa
Middle name
Last name Tani

Organization

Nihon University Hospital

Division name

Health Planning Center of Nihon University Hospital

Zip code

101-0062

Address

1-6 Kandasurugadai, chiyodaku, Tokyo, Japan

TEL

09080537841

Email

tani.shigemasa@nihon-u.ac.jp


Public contact

Name of contact person

1st name Shigemasa
Middle name
Last name Tani

Organization

Nihon University Hospital Health Planning Center

Division name

Nihon University Hospital Health Planning Center

Zip code

101-0062

Address

1-6 Kandasurugadai, chiyodaku

TEL

09080537841

Homepage URL


Email

tani.shigemasa@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University Hospital

Institute

Department

Personal name

Shigemasa Tani


Funding Source

Organization

Nihon University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon University Hospital IRB

Address

Kandasurugadai1-6, Chiyodaku, Tokyo

Tel

09080537841

Email

tani.shigemasa@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 04 Month 01 Day

Date of IRB

2023 Year 10 Month 01 Day

Anticipated trial start date

2024 Year 03 Month 01 Day

Last follow-up date

2024 Year 03 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cross-sectional study


Management information

Registered date

2024 Year 02 Month 23 Day

Last modified on

2025 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061272